Neurohk s.r.o.

Neurohk s.r.o. is conducting studies that target pain and movement disorders, aiming to improve symptom relief and functional outcomes for patients with chronic conditions.

• chronic non-specific low back pain
• cervical dystonia
• musculoskeletal pain management

The research focuses on evaluating new therapeutic approaches to reduce pain intensity and enhance quality of life for individuals whose standard treatments have been insufficient.

The site’s neurology program investigates treatments for progressive neurological disorders, seeking to slow disease progression and preserve motor and cognitive function.

• relapsing‑remitting multiple sclerosis
• early Parkinson's disease
• migraine prevention and acute therapy

By testing innovative agents, researchers aim to provide safer, more effective options for patients living with these chronic nervous‑system diseases.

Clinical work at Neurohk s.r.o. addresses neuropsychiatric symptoms that significantly impact daily living, with a focus on developing therapies that lessen severe behavioral disturbances.

• agitation associated with Alzheimer’s disease
• Alzheimer’s disease psychosis
• Lewy body dementia psychosis
• hallucinations and delusions in dementia

The trials evaluate safety and efficacy of novel compounds to improve behavioral outcomes and reduce caregiver burden in affected individuals.

Research into core psychological symptoms accompanies the site’s broader neuro‑psychiatric agenda, aiming to refine treatment strategies for complex mental presentations.

• agitation in dementia
• hallucinations
• delusions
• mood and cognitive disturbances

Findings from these studies are intended to guide clinicians toward more precise, patient‑centered interventions for challenging psychological phenomena.